Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription

Articles published in Bone Marrow Transplant

Retrieve available abstracts of 5 articles:
HTML format

Single Articles

    April 2021
  1. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    PubMed     Abstract available

  2. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.

    February 2020
  3. ZHANG P, Liu B
    Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis.
    Bone Marrow Transplant. 2020 Feb 4. pii: 10.1038/s41409-020-0810.
    PubMed     Abstract available

    November 2019
  4. TAPPENDEN P, Wang Y, Sharrack B, Burman J, et al
    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Workin
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0747.

    September 2019
  5. SHARRACK B, Saccardi R, Alexander T, Badoglio M, et al
    Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0684.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.